Related references
Note: Only part of the references are listed.Off-study utilization of experimental therapies: Analysis of GOG249-eligible cohorts using real world data
Parth A. Chodavadia et al.
GYNECOLOGIC ONCOLOGY (2020)
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
Alicia Leon-Castillo et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Evolving trends in the management of high-intermediate risk endometrial cancer in the United States
Sara J. Zakem et al.
GYNECOLOGIC ONCOLOGY (2019)
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
Stephanie M. de Boer et al.
LANCET ONCOLOGY (2019)
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
Daniela Matei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Chemotherapy, Radiation, or Combination Therapy for Stage III Uterine Cancer
Sbaa Syeda et al.
OBSTETRICS AND GYNECOLOGY (2019)
Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: Outcomes by risk factors
Ken Tatebe et al.
GYNECOLOGIC ONCOLOGY (2019)
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Stephanie M. de Boer et al.
LANCET ONCOLOGY (2018)
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
B. G. Wortman et al.
BRITISH JOURNAL OF CANCER (2018)
Utility of radiation therapy for early-stage uterine papillary serous carcinoma
Stephanie Cham et al.
GYNECOLOGIC ONCOLOGY (2017)
Using the National Cancer Database for Outcomes Research
Daniel J. Boffa et al.
JAMA ONCOLOGY (2017)
Overuse of external beam radiotherapy for stage I endometrial cancer
Jason D. Wright et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
R. A. Nout et al.
LANCET (2010)
A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study
Howard D. Homesley et al.
GYNECOLOGIC ONCOLOGY (2009)
The National Cancer Data Base: A powerful initiative to improve cancer care in the United States
Karl Y. Bilimoria et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study
Nobuyuki Susumu et al.
GYNECOLOGIC ONCOLOGY (2008)
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study
ME Randall et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
HM Keys et al.
GYNECOLOGIC ONCOLOGY (2004)
Phase III randomized trial of doxorubicin plus cisplatin versus doxorubicin+24-h paclitaxel plus filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study
GF Fleming et al.
ANNALS OF ONCOLOGY (2004)
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A gynecologic oncology group study
GF Fleming et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: A gynecologic oncology group study
JT Thigpen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma:: multicentre randomised trial
CL Creutzberg et al.
LANCET (2000)
Share Paper
